Back to News
Market Impact: 0.25
Rallybio Corporation Postpones Merger Closing Originally Scheduled for November 6, 2026
Source: Nasdaq
M&A & RestructuringHealthcare & Biotech
Rallybio said the merger and reorganization transactions with Avenzo Therapeutics and Farmington Merger Sub did not close on the previously anticipated date. The article provides no reason for the delay or revised closing timetable.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
RLYB-0.45
More News
- Berkshire Hathaway stock is a haven again as investors flee AI bloodbath while its own portfolio takes a hit amid reshuffling
- argenx reports positive phase 3 data for autoimmune myositis drug
- SoftBank, ABB consider China carve-out to rescue $5.4bn robotics deal
- InvestingPro’s Fair Value spotted 66% gain in Array Technologies
- Voters turn on AI data centers, Shield AI's $5.3B Echodyne deal, and a Seattle startup's rare double exit
- How Bankrupt Wine Distributor RNDC Preserved 6,000 Jobs